Medicinal product name Zelboraf
Pharmaceutical form Film-coated tablet
Strength 240 mg 
Information from the MAH on shortages No information on expected shortages
Availability of medicinal product
Product No.Package sizeWholesalers' stock state
EU/1/12/751/001 KZSN56 Is available
Legal status Rx Prescription (Pr.)
KZS NHS Reimbursed medicines
Summary of product characteristics, package leaflet and labeling text  Summary of product characteristics, patient information leaflet and labeling text approved by the European Medicines Agency is available on European Medicines Agency website
ATC code L01EC01 Antineoplastic agents

Medicinal products (1)

Availability of medicinal product Wholesalers Package size, content Primary packaging Maximum admissible pharmacy price (€ incl. VAT) Product No. Labelling
 Is available (according to the information provided by wholesalers)
(381 containers)
Roche Latvija N56
(240 mg)
Al/Al blister 2037.10 
KZS*
EU/1/12/751/001  Summary of product characteristics, patient information leaflet and labeling text approved by the European Medicines Agency is available on European Medicines Agency website
* Indication about medicine on the List of state reimbursed medicines is just informative. Source of the information is the National Health Service. For details please visit the NHS website.

Registration information

Marketing authorisation No. EU/1/12/751/001
Date of authorisation Feb 17, 2012
Marketing authorisation holder, country Roche Registration GmbH, Germany